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HIV/AIDS, TO DISCLOSE OR NOT TO DISCLOSE: THAT IS THE QUESTION 
 
A le Roux-Kemp
 
 
1  Introduction 
 
An  estimated  22.5  million  people  (including  2.3  million  children)  were  living  with 
HIV/AIDS in Sub-Saharan Africa at the end of 2009. It is furthermore estimated that 
approximately 1.3 million Africans died of AIDS in 2009.
1 According to the  South 
African National HIV Survey of 2008, it is estimated that 10.9% of South Africans 
older than two years are living with HIV/AIDS, and among those between the ages 
of 15 and 49 years the estimated HIV prevalence is 16.9%.
2 These figures remain 
staggering and it therefore comes as no surprise that the   impact and effect of 
HIV/AIDS are  no  longer  limited to mortality rates and illness es  but are actually 
widespread and influence all aspects of our everyday lives.  The health care sector, 
households, schools, workplaces and  the economy - all of these are  experiencing 
distinct challenges due to the high HIV/AIDS prevalence rate, and appropriate action 
must therefore be taken to deal with these challenges in their different contexts. 
 
Yet, despite the high prevalence rate of HIV/AIDS and the global challenges this 
pandemic poses for all a person’s HIV status remains a private affair, primarily due 
to the way in which it is generally transmitted and the lack of a cure; "... HIV is a 
condition  related  to  sex,  death  and  disease  –  topics  that  allude  to  the  most 
existential aspects of life and are therefore perceived as highly intimate".
3 This was 
confirmed in NM v Smith, where it was held that— 
 
... an individual’s HIV status deserves protection against indiscriminate disclosure 
due  to  the  nature  and  negative  social  context  the  disease  has,  as  well  as  the 
potential intolerance and discrimination that result from its disclosure.
4  
                                                 
   Andra le Roux-Kemp. BA LLB LLD (Stell). Part-time lecturer, Stellenbosch University. Researcher, 
Freie Universität Berlin. Email: andra@sun.ac.za.  
1   Avert Date unknown http://bit.ly/XQn7tr; UNAIDS 2010 http://bit.ly/13Ipzu8. 
2   Avert Date unknown http://bit.ly/16pKTCh. 
3   Roehrs 2009 SALJ 369; Maile 2004 Africa Education Review 113-127. 
4   NM v Smith 2007 5 SA 250 (CC) para 42; Roehrs 2009 SALJ 369.  A LE ROUX-KEMP    2013(16)1 PER / PELJ 
 
202 / 536 
 
 
Ethical problems in the management of the disclosure of a person’s HIV status have 
certainly  also  increased.
5  Numerous examples exist where people have suffered 
discrimination,  were  treated  unfairly,  were  denied  employment  or  access  to 
particular services and/or institutions based only on their HIV-status.
6  
 
This article provides a comprehensive summary of the position regarding HIV/AIDS 
and disclosure in South Africa.
7 The primary aim of the article is to consider and 
comment  on  the  practical  man ifestations  and  considerations  of  HIV/AIDS  and 
disclosure that different role players in the economy, criminal justice system and the 
health care industry in South Africa are confronted with. The consensual and non-
consensual  disclosure  of  a  person’s  HIV/AIDS  status  and  related  information  in 
different  contexts  will  consequently  be  discussed  to  illustrate  the  diversity  of 
approaches utilised under different circumstances and the underlying considerations 
in each instance. Reference will therefore be made to relevant legislation, case law, 
and academic literature as well as ethical guidelines and protocols like the Code of 
Good  Practice  of  the  Employment  Equity  Act  55  of  1998,  the  Health  Professions 
Council of South Africa’s ethical rules and the ethical guidelines of the South African 
Medical Association. 
 
It will become evident from this discussion of the disclosure of HIV/AIDS status in 
different contexts that  there is often no simple answer or single approach to be 
followed. Whether a person him- or herself should disclose their status or whether a 
health care worker or employer/another employee should disclose this information is 
largely  determined  by  the  particular  circumstances  of  each  and  every  situation. 
                                                 
5   Maile 2004 Africa Education Review 113-127. 
6   Maile 2004  Africa Education Review 113-127; Hoffmann v South African Airways  2001 1 SA 1 
(CC); Allpass v Mooikloof Estates (Pty) Ltd t/a Mooikloof Equestrian  Centre 2011 2 SA 638 (LC); 
Irvin and Johnson Limited v Trawler and Line Fishing Union and Others  2003 24 ILJ 565 (LC); 
Joy Mining Machinery a division of Harnischfeger (South Africa) (Pty) Limited v National Union of 
Metal Workers of South Africa (NUMSA)  2002 ZALC 7; NM v Smith 2007 5 SA 250 (CC); Jansen 
van Vuuren v Kruger 1993 4 SA 842 (AD). 
7   This is not a legal comparative study. It is rather a comprehensive exposition on the South 
African experience of HIV/AIDS disclosure in different contexts. A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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Some  general  principles  based  on  the  constitutional  rights  to  privacy,
8  human 
dignity
9  and  the  right  to  bodily  and  psychological  integrity
10  can  however  be 
extracted from the case studies and discussion below.  
 
2  Disclosure and the larger economy   
 
In  a  2006  study  on  the  status  of  HIV/AIDS  reporting,  De  Bruyn  submitted  that 
HIV/AIDS is most prevalent amongst the economically active groups in South Africa 
and  that  this  could  ultimately  change  the  demographic,  social  and  economic 
landscape of the country.
11 It was furthermore submitted that the high prevalence of 
HIV/AIDS in South Africa had already had a systematic economic impact in the work 
place, as companies  were already experiencing a lack of productivity due to staff 
absenteeism  as  a  result  of  AIDS-related  illnesses  and  the  need  to  grant 
compassionate leave. Employees  attending the funerals of   relatives, friends and 
colleagues who had died of AIDS was also said to  be contributing to the negative 
economic impact of  HIV/AIDS at the workplace.
12  In addition, companies  were 
incurring  additional  costs  from  having  to   provide  anti-retroviral  drugs  to  their 
employees, increased recruitment and training costs in the case of a n HIV-positive 
employee dying or being incapacitated, general healthcare costs, increased death 
and disability benefits  expenses, and the cost of in -house HIV/AIDS management 
programmes.
13  
 
In  the  light of these exorbitant expenses and  the  negative economic impact of 
HIV/AIDS on companies, it is quite comprehensible that investors and shareholders 
would expect companies to voluntarily disclose informati on about the HIV/AIDS 
prevalence rate amongst their employees.
14 While some companies listed on the JSE 
                                                 
8   Section 14 Constitution of the Republic of South Africa, 1996.  
9   Section 10 Constitution of the Republic of South Africa, 1996.  
10   Section 12(2) Constitution of the Republic of South Africa, 1996. 
11   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 2.  
12   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 2. 
13   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 2. 
14   Mandatory disclosure refers to those aspects and items of information that are required by 
statutes, stock exchanges or prescribers of accounting standards. The disclosure is accomplished 
through company annual reports. Voluntary disclosure, on the other hand, is disclosure in excess A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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Securities  Exchange  do  include  such  information  in  their  annual  reports  on  the 
impact  of  HIV/AIDS  on  their  operations,  no  accounting  standard/pronouncement 
exists to guide companies in this regard.
15 However, both the King Report II
16 and 
the Global Reporting Initiative (GRI)
17 encourage companies to understand the social 
and economic impact that HIV/AIDS has on its business activities, to adopt an 
appropriate strategy to deal with it, and to devise plans and policies to address and 
manage the impact. It is also suggested that companies should regularly monitor 
their performance  with regard to HIV/AIDS and report  back to all stakeholders.
18 
The  JSE  Securities  E xchange  and  the  South  African  Institute  of  Chartered 
Accountants (SAICA) also advocate a more formal approach to HIV/AIDS reporting 
by companies.
19  
 
The GRI, in a document entitled   Reporting Guidance on HIV/AIDS: A Resource 
Document,
20  identifies four areas  that need to be addressed when reporting on 
HIV/AIDS: 
 
•  Good governance, including HIV/AIDS policy, strategies for managing the risk, 
as well as the monitoring and reporting of these and related issues; 
•  Measuring, monitoring and evaluation, including HIV/AIDS-related costs and 
losses and future costs and losses due to HIV/AIDS; 
•  Workplace  conditions  and  HIV/AIDS  management,  including  stakeholder 
involvement  in  policy  formulation,  workplace-related  programmes  and 
interventions, as well as the budgets for these programmes; and 
•  The  depth,  quality,  and  sustainability  of  programmes  that  aim  to  prevent 
further infections and support those employees already infected.
21  
                                                                                                                                                        
of the requirements and represents free choices on the part of company management to provide 
accounting and other information deemed relevant to the decision needs of users of the annual 
reports (Myburgh 2001  Meditari Accountancy Research 199-216; Mokoaleli-Mokoteli and Ojah 
2010 African Finance Journal 5). Also see De Bruyn 2008 Meditari Accountancy Research 59-78. 
15   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 2. 
16   Institute of Directors King Report II. 
17   The GRI is is a non -profit organisation that works towards a sustainable global economy by 
providing sustainability reporting guidance. See www.globalreporting.org. 
18   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 6. 
19   Also see De Bruyn 2008 Meditari Accountancy Research 59-78. 
20   GRI  Reporting  Guidance  on  HIV/AIDS:  A  Resource  Document  10-16,  accessible  at 
http://bit.ly/ZwyIxe. A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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At  present,  approximately  72%  of  JSE-listed  companies  voluntarily  disclose  some 
information on HIV/AIDS, while 28% of the companies do not report on the impact 
of HIV/AIDS on  their operations at  all.  A  mere 11.41%  of the companies  report 
financial information related to the impact of HIV/AIDS on their operations.
22 This 
result shows that companies in South Africa are generally not very willing to report 
about the impact of HIV/AIDS on their financial operations.
23 Many reasons may 
exist  for  this  lack  of  disclosure  but  Mokoaleli-Mokoteli  and  Ojah  highlight  the 
following three as the main reasons for non-disclosure: 
 
a)  Firms  are  not  obliged  to  disclose  HIV/AIDS-related  information  and  therefore 
prefer not to disclose additional information; 
b)  No  standard  or  guideline  on  how  HIV/AIDS  should  be  reported  for  financial 
reporting purposes exists; and 
c)  Some firms may not want to disclose this sensitive information for all (including 
their competitors) to read.
24 
 
Although it is evident that many companies in South Africa do not currently report 
on  the  systemic  and  economic  effects  of  HIV/AIDS  on  their  business,  the  need 
definitely  exists,  especially  amongst  shareholders,  for  such  reporting  in  terms  of 
standard  financial  reporting  guidelines.  The  disclosure  of  HIV/AIDS-related 
information by JSE-listed companies would not only assist in providing a picture of 
the impact of HIV/AIDS on the demographic, social and economic landscape of the 
country but it would also allow for companies to determine the systematic economic 
impact of HIV/AIDS in the workplace and the positive role that company-specific HIV 
management programmes and interventions could play in this regard. 
 
                                                                                                                                                        
21   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 6. 
22   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 15. 
23   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 20. 
24   Mokoaleli-Mokoteli and Ojah 2010 African Finance Journal 20. A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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3  Disclosure and the workplace 
 
But  whether  or  not  to  disclose  your  HIV/AIDS  status  at  the  workplace/to  your 
employer is certainly a thorny issue. The Code of Good Practice on Key Aspects of 
HIV/AIDS and Employment (hereafter the "Code of Good Practice")
25 issued by the 
minister of labour in terms of the  Employment Equity Act unequivocally states that 
no employer may require an employee or an applicant for employment to undertake 
an HIV test in order to ascerta in  the  employee’s  HIV  status.
26  Employers  can, 
however, approach the Labour Court in terms of sections 7 and 50(4) of the Act to 
obtain  authorisation  for  such  testing.  But  this  will  be  granted  only  if  existing 
legislation permits or requires such testing or if the testing is justifiable in the light of 
medical facts, employment conditions, social policy, the fair distribution of employee 
benefits or the inherent requirements of the particular job/position.
27 (It should be 
noted, however, that these provisions do not prohibit cases of permissible testing in 
the workplace where an employer provides HIV testing, counselling and treatment to 
employees as part of a healthcare service plan, or in the event of an occupational 
accident carrying a risk of exposure to b lood or bodily fluids or for the purposes of 
applying for compensation following an occup ational accident.)
28  Employees are 
furthermore under no obligation to disclose their HIV status to their employers or to 
other  employees  and  where  such  information  has  been  disclosed,  the  express 
consent of the particular individual must be obtained before this information may 
also be disclosed to others.
29 
 
In an interesting case concerning pre-employment testing, the Constitutional Court 
had to decide whether an HIV -testing employment policy of  the South African 
Airways was justified in terms of the Code of Good Practice and the  Employment 
Equity Act. The appellant in the case of Hoffmann v South African Airways 2001 SA 1 
                                                 
25   The Code of Good Practice is accessible at http://bit.ly/X8P9Do. 
26   Clause 7.1 of the Code of Good Practice.  
27   Section 7(1) Employment Equity Act 55 of 1998.  
28   Clause 7.1 of the Code  of Good Practice; See  Irvin and Johnson Limited v Trawler  and Line 
Fishing Union  2003 24 ILJ 565 (LC);  Joy Mining Machinery a division of Harnischfeger (South 
Africa) (Pty) Limited v National Union of Metal Workers of South Africa (NUMSA) 2002 ZALC 7. 
29   Clause 7.2 of the Code of Good Practice.  A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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(CC) applied for a position as a cabin attendant at South African Airways, and at the 
end  of  a  four-stage  selection  procedure  he  was  one  of  only  twelve  remaining 
suitable  candidates  identified  by  the  SAA  for  appointment.  However,  the 
appointment  was  subject  to  undergoing  a  pre-employment  medical  examination 
which included a blood test for HIV/AIDS. While the medical examination found the 
appellant to be clinically fit and suitable for employment, the blood test showed that 
the appellant was HIV positive. SAA consequently informed the appellant that he 
could not be employed as a cabin attendant because of his HIV-positive status.   
 
SAA defended its decision and employment policy, contending that no person who is 
HIV positive can work as a cabin attendant since the SAA flight crew must be fit to 
travel  world-wide  and  must  be  fit  to  be  vaccinated  against  various  ailments, 
including yellow fever, a vaccination to which HIV-positive people do not react too 
well, and consequently cannot receive. Without the vaccination, HIV-positive cabin 
crew members would be at risk of contracting yellow fever and they would pose a 
risk of transmitting it to others, including the passengers. In addition, it was argued 
that HIV-positive persons are also at risk of contracting opportunistic diseases and 
that  this  also  posed  the  risk  of  transmitting  the  diseases  to  others,  including 
passengers.  
 
The High Court
30 agreed with the decision made by the SAA and found that the 
employment practice of the SAA was based on considerations of medical safety and 
operational grounds that did not exclude persons with HIV from employment in all 
positions within SAA, but only from cabin-crew positions. It was also found that the 
employment practice was aimed at achieving a worthy and important societal goal.
31 
The Constitutional Court  found, however, based on the medical evidence, that an 
asymptomatic  HIV-positive  person  could  indeed  perform  the  work  of  a  cabin 
attendant competently and that any hazards to which  an immunocompetent cabin 
attendant  might  be  exposed  to  could  be  managed  by  counselling,  m onitoring, 
vaccination  and  the  administration  of  the  appropriate  antibiotic  prophylaxis  if 
                                                 
30   Hoffmann v South African Airways 2000 2 SA 628 (W).  
31   Hoffmann v South African Airways 2000 2 SA 628 (W) para 28. A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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necessary.
32  The  risks  to  passengers  and  other  third  parties  arising  from  the 
employment of  an asymptomatic HIV-positive cabin crew member was  therefore 
inconsequential,  and  well-established  universal  precautions  could  be  utilised  to 
minimise any possible risk.
33 The fact that the SAA was testing only individuals who 
applied for positions at SAA and not those who were already in their employ was 
also questioned. This, the court found, was irreconcilable with the stated purpose of 
SAA’s  employment  practice.
34  The  Constitutional  Court  found  in  favour  of  the 
appellant,  stating  that  the  refusal  by  SAA  to  employ  the  appellant  as  a  cabin 
attendant because he was HIV positive violated his right to equality guaranteed by 
section 9 of the Constitution.
35 
 
In another case,  Allpass v Mooikloof Estates (Pty) Ltd t/a Mooikloof Equestrian 
Centre
36 a horse-riding instructor and stable manager was dismissed by Mooikloof 
Estates  for  being  HI V  positive  and  not  having  disclosed  this  during  the  pre -
employment interview.  Although the applicant  had been  asked about his health 
during the pre-employment interview he  had  not divulged  his HIV-status,  even 
though he had been living with HIV for some 17 years at that stage.
37 It was only a 
few  days  after  the  applicant’s  appointment,  when  he  was  asked  to  complete  a 
personal particulars form — which included questions on his health, allergies and 
chronic medication — that the applicant’s HIV status became known to his employer. 
The  respondent,  Mooikloof  Equestrian  Centre,  argued  that  the  applicant  had  not 
been honest in his pre-employment interview and that  the particular position for 
which  the  applicant  applied  required  long  working  hours  including  nights  and 
weekends,  thus  generally  requiring  good  health  and  well-being.  Although  the 
respondent agreed that the applicant was under no duty to disclose his status, the 
respondent contended that it was dishonest for someone with HIV to claim good 
health, not because it implied that the person was unhealthy, but because it was a 
                                                 
32   Hoffmann v South African Airways 2001 1 SA 1 (CC) para 15.  
33   Hoffmann v South African Airways 2001 1 SA 1 (CC) para 15.  
34   Hoffmann v South African Airways 2001 1 SA 1 (CC) para 31.  
35   Hoffmann v South African Airways 2001 1 SA 1 (CC) para 41. 
36   Allpass v Mooikloof Estates (Pty) Ltd t/a Mooikloof Equestrian Centre 2011 2 SA 638 (LC). 
37   Allpass v Mooikloof Estates (Pty) Ltd t/a Mooikloof Equestrian Centre 2011 2 SA 638 (LC) para 6.  A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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realistic  factor  impacting  on  that  person’s  health  and  potentially  also  on  his/her 
job.
38 
 
However, both the applicant and his medical expert contended that the applicant 
was in excellent health, as he consistently adhered to a proper treatment regime, his 
CD4 count was at all times exceptionally low and his viral load was at such a low 
level as to be indetectable. It was  also submitted that the applicant was able to 
perform his duties at all material times.
39 The court agreed with this and found that 
the respondent’s primary concern was indeed the applicant’s HIV status and that it 
was the sole reason for his dismissal. Based on the evidence, it was clear that the 
applicant had no medical or physical impediment preventing him from performing his 
duties and it was also evident that the applicant had acquitted himself well in a 
strenuous and demanding job.
40 The applicant’s good health and ability to perform 
his duties at all material times were consequently the decisive considerations in this 
judgement.  
 
It is evident from the discussion above that pre-employment HIV testing and the 
mandatory  disclosure  of  an  employee’s  HIV  status  will  be  warranted  only  in 
exceptional  circumstances  where  existing  legislation  allows  for  it,  or  where  it  is 
justifiable in the light of medical facts, employment conditions, social policy, the fair 
distribution  of  employee  benefits,  or  the  inherent  requirements  of  the  particular 
job/position. This thorough protection of HIV positive individuals’ right to privacy in 
the  workplace  is  indeed  necessary,  as  unfair  discrimination  against  HIV-infected 
employees is rife, and further stigmatisation — that HIV-infected persons are a risk 
at the workplace in particular and for communities at large — should be avoided as 
far as possible.
41  
 
                                                 
38   Allpass v Mooikloof Estates (Pty) Ltd t/a Mooikloof Equestrian Centre 2011 2 SA 638 (LC) para 
19.  
39   Allpass v Mooikloof Estates (Pty) Ltd t/a Mooikloof Equestrian Centre 2011 2 SA 638 (LC) para 6.  
40   Allpass v Mooikloof Estates (Pty) Ltd t/a Mooikloof Equestrian Centre  2011 2 SA 638 (LC) para 
54.  
41   SALRC Pre-employment HIV-testing 2.49.  A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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4  Non-consensual disclosure by a health practitioner  
 
Yet, before an HIV-infected person is confronted with the question of disclosure in 
the workplace, the very first relationship where this private and intimate information 
is shared is the relationship between the patient and his/her healthcare worker. This 
relationship between a medical practitioner and a patient is a unique and intimate 
relationship that requires the utmost respect for the patient’s rights to privacy and 
dignity.  
 
In the landmark case of Jansen van Vuuren v Kruger
42 a medical practitioner  had 
disclosed the HIV status of his patient  — after an explicit request by the patient to 
keep the information confidential — to other health practitioners during the course 
of  a  game  of  golf.  The  patient/plaintiff  instituted  proceedings  claiming  that  the 
medical practitioner owed him a duty of confidentiality in  regard of their doctor-
patient  relationship  and  regarding  any  knowledge  of  the  plaintiff’s  medical  and 
physical condition. The plaintiff argued that he had suffered an invasion of privacy 
and had been injured in his rights of personality. The medical practitioner, however, 
argued that the disclosure had been made on a privileged occasion, that it was the 
truth, and made in the public interest, and that it was objectively reasonable in the 
public interest in the light of the boni mores. The medical practitioner contended 
that he had a social  and moral duty to make the disclosure to the other health 
practitioners and that they had a reciprocal social and moral right to receive the 
information  and  apply  due  diligence  when  again  dealing  with  or  treating  the 
plaintiff.
43  
 
In  this  case it  was  highlighted  that  a  sense  of  the   importance  of  maintaining 
confidentiality about the information acquired in a medical practitioner’s professional 
capacity even predated Hippocrates and should always be honoured at all costs.
44 
This is important not only to protect the privacy of patients but  it is also the  only 
                                                 
42   Jansen van Vuuren v Kruger 1993 4 SA 842 (AD). Also see Van Wyk 1994 THRHR 141. 
43   Jansen van Vuuren v Kruger 1993 4 SA 842 (AD) 38.  
44   Jansen van Vuuren v Kruger 1993 4 SA 842 (AD) 11 – 12. A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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way of securing public health, as doctors would otherwise be discredited.
45 This duty 
of medical practitioners to respect the confidence of their patients is furthermore not 
merely an ethical duty but it is also a legal duty recognised by South African  
common law.
46 This was reiterated in the case of NM v Smith.
47 
 
The applicants in the case of NM v Smith claimed that their rights to privacy, dignity 
and psychological integrity had been violated as their names and the fact that they 
were HIV positive had been disclosed, without their prior consent, in  the biography 
of Ms Patricia de Lille, a publication that  had been authored by Ms Charlene Smith. 
The applicants’ details were included in the book in a chapter discussing Ms de Lille’s 
work in campaigning for the rights of people living with HIV/AIDS. The applicants’ 
details were relevant to the discussion as they were involved in a clinical trial that 
was the source of some complaints as well as an ethical enquiry in which Ms de Lille 
gave her assistance and support. Ms Smith, the author of the biography, made use 
of an external report, that had been e-mailed to Ms de Lille as well as two other 
journalists, and that detailed the information on the clinical trial, the complaints, and 
the ethical enquiry into the trial.  
 
The external report did not contain the informed consent forms of the applicants and 
it was furthermore not marked as confidential. Had the informed consent forms of 
the applicants been attached to the report it would, however, have become clear 
that the consent forms signed by the applicants did not permit full public disclosure 
of their identity and the fact that they were living with HIV/AIDS. The consent forms 
permitted only limited disclosure for the purposes of the University’s investigation 
into the clinical trial and the complaints received. While the respondents admitted 
publication  of  the  applicants’  names  and  their  HIV  status  they  denied  that  the 
publication  was  intentional  or  negligent  and  pleaded  that  the  HIV  status  of  the 
applicants was no longer private at the time of the publication of the book. They also 
argued that it was reasonable for any reader of the external report to assume that 
                                                 
45   Jansen van Vuuren v Kruger 1993 4 SA 842 (AD) 13 – 14. 
46   Jansen van Vuuren v Kruger 1993 4 SA 842 (AD) 14. 
47   NM v Smith 2007 5 SA 250 (CC). Also see Neethling 2008 SALJ 36-46; Scott 2007 Stell L R 483-
494. A LE ROUX-KEMP    2013(16)1 PER / PELJ 
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the necessary consent had been obtained since nothing in the report indicated that it 
was confidential. The applicants, however, argued that their rights of personality, 
privacy,  dignity  and  psychological  integrity  had  been  violated  as  a  result  of  the 
disclosure, and that they had suffered damages.  
 
Justice Madala from the Constitutional Court held that the lack of respect for private 
medical information and its subsequent disclosure might result in fear, jeopardising 
an individual’s right to make certain fundamental choices that he/she has a right to 
make.
48 Especially with regard to the disclosure o f an individual’s HIV/AIDS status, 
the court held that confidentiality was important as it would encourage individuals to 
seek treatment and divulge information encouraging disclosure of HIV, and that it 
might also result in the improvement of public health policies on HIV/AIDS.
49 Medical 
information was furthermore not only private and confidential while in the hands of 
health  care  personnel .  People  continued  to  have  a  direct  interest  to  control 
information  about  themselves  and  to  keep  it  confidential.  Thus ,  although  the 
applicants  had  given  their consent to take part in  the clinical trial  and in  the 
consequent enquiry that was held, they certainly  had not given consent for their 
names to be published in a book having a wide circulation throughout South Africa.
50 
 
The doctor-patient relationship  is possibly one of the most important relationships 
that can come into being between any two people. The relationship is based on 
trust, morality and respect, and it is vital to the quality of the care provided as well  
as to the outcomes and relative success of the specific medical intervention and 
treatment.
51 This duty of medical practitioners to respect the confidentiality of their 
patients is both an ethical and a legal duty and extends even beyond the limits of 
the relationship between patient and medical practitioner.  It was evident from the 
judgment in the case of  NM v Smith that it can never be assumed that others are 
allowed  access  to  private  medical  information  once  it  has  left  the  hands  of 
authorised physicians and other personnel involved in the facilitation of medical care. 
                                                 
48   NM v Smith 2007 5 SA 250 (CC) para 41.  
49   NM v Smith 2007 5 SA 250 (CC) para 42.  
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It  can  consequently  be  concluded  that  the  confidentiality  of  medical  information 
obtained  by  a  medical  practitioner  in  his/her  professional  capacity  is  one  of  the 
cornerstones of health care and — especially with regard to the disclosure of HIV 
and related information — this fundamental aspect of medical care and relationships 
even extends beyond the boundaries of the health care milieu. 
 
5  Non-consensual disclosure: Unauthorised blood tests 
 
In terms of rule 9.4 of the Health Professions Council of South Africa’s ethical rules, 
informed  consent  is  a  prerequisite  for  testing  a  person  for  HIV.  Even  where 
healthcare practitioners are expected to record diagnostic information for patients on 
medical insurance forms or in accordance with the rules of a medical scheme, the 
patient  must  give  informed  consent  for  such  information  to  be  placed  on  the 
account.  
 
This general principle was reiterated in C v Minister of Correctional Services,
52 but it 
was  completely disregarded in the case of  VRM v Health Professions Council of 
South Africa.
53 In the latter case a woman, six months pregnant, consulted with the 
medical practitioner whom she wanted to deliver her baby. During this consultation a 
blood sample was taken. At a follow-up consultation the patient and her husband 
enquired about the blood test and the account they had received for it as the 
account made mention of HIV Elisa and they wanted to know whether the blood test 
had anything to do with HIV/AI DS. The medical practitioner denied that the blood 
test was for HIV and offered to take it up with the pathologists who conducted the 
test and had sent the account. However, after the patient’s baby was stillborn the 
medical  practitioner  informed  her  that  the  blood  test  taken  during  the  first 
consultation was indeed for HIV testing and that she was HIV positive. The medical 
practitioner also stated that her baby had been HIV positive and that it was the 
reason for the baby’s stillbirth. 
 
                                                 
52   C v Minister of Correctional Services 1996 4 SA 292 (T). Also see Knobel 1997 THRHR 533-536. 
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In this case the conduct of the medical practitioner was questioned as illegal and 
unethical, it was alleged that he had performed an unauthorised HIV test on both 
the patient and the baby, that he had not provided the requisite counselling before 
and after the HIV test, he had not disclosed the outcome of the test as soon as it 
became known to him, and he had not advised, acted and provided treatment to 
reduce the risk of mother-to-child HIV transmission. It was also asked if the medical 
practitioner had the requisite consent from the patient to inform her husband of her 
HIV-positive status.
54 The medical practitioner, however, defended his conduct  on 
the grounds that the patient’s right to security in and control over her body in terms 
of  section  12(2)(b)  of  the  Constitution  had  violated  because  there  were  no 
counselling facilities at the specific hospital and that he had exercised his discretion 
in not informing the patient of her status immediately upon the outcome of the test 
since he thought it was in her best interests, from a psychological point of view, not 
to do so.
55  
 
In a most unsatisfactory and shocking judgement  the High Court found that it was 
"…difficult to understand in what respect [the patient’s] constitutional rights were 
violated".
56 The court held that there  were, in any event, very few choices/options 
available to the patient , as she had been  six months pregnant already,  that the 
hospital lacked counselling facilities  and  "...the fact that she was informed later 
instead of sooner was really of no moment at that stage".
57 The court went on to 
say that "...the difference between informed  consent and consent is marginal" and 
had very little import in the case at hand.
58  Justice  H  Daniels surprisingly found 
"...no room for the contention that [the medical practitioner] arrived at a decision in 
a paternalistic and capricious manner".
59  
 
                                                 
54   VRM v Health Professions Council of South Africa 2002 ZAGPHC 4 para 24. Also see part 6 of this 
article. 
55   VRM v Health Professions Council of South Africa 2002 ZAGPHC 4 9.  
56   VRM v Health Professions Council of South Africa 2002 ZAGPHC 4 13. 
57   VRM v Health Professions Council of South Africa 2002 ZAGPHC 4 14. 
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It is submitted that the judgement in the case of VRM v Health Professions Council 
of South Africa is wide of the mark and that no situation or circumstance can ever 
warrant the use of unauthorised HIV blood tests without a patient or individual’s 
informed consent. To act otherwise would be a serious infringement of a patient’s 
constitutional rights, especially the right to psychological and bodily integrity.
60 
 
6  Non-consensual disclosure: by a health practitioner to an intimate 
partner and/or family member  
 
Of particular concern for healthcare practitioners — and this issue too was raised in 
the case of VRM v Health Professions Council of South Africa discussed above — is 
whether  or  not  to  disclose  the  HIV-status  of  a  patient  to  that  patient’s 
spouse/partner.  The  ethical  conflict  between  the  healthcare  practitioner’s  duty  to 
respect  the  patient’s  right  to  privacy  and  confidentiality  weighs  heavily  in  such 
circumstances  against  the  general  duty  of  all  healthcare  practitioners  to  inform 
individuals of possible health risks. While UNAIDS, the Canadian Advisory Committee 
and the American Medical Association have made provision for partner notification - 
first  with  the  source  patient’s  informed  consent  and  in  limited  circumstances
61 
without such consent – no comparable partner notification programmes or guidelines 
exist in South Africa.
62 
 
Instead, rule  9  of  the  Health  Professions  Council  of  South  Africa’s  ethical  rules 
provides  for  situations  where  an  HIV-infected  patient  refuses  to  inform  his/her 
intimate partner of his or her status.
63 In such situations it is recommended that 
health care workers use their discretion on whether or not to divulge the information 
to the patient’s intimate partner. The possible risk of HIV infection to the intimate 
partner, as well as the risks to the patient of disclosing his or her status, must be 
                                                 
60   Section 12(2) Constitution of the Republic of South Africa, 1996. 
61   Partner  notification  without  the  source  client/patient’s  consent  will  be  permissible  where  the 
source client fails to apply appropriate behavioural changes (eg practising safe sex), the partner 
of the patient is clearly identified, and that partner is at a real risk of HIV transmission or has 
little or no reasonable suspicion of the risk; Roehrs 2009 SALJ 377. 
62   For a discussion of whether or not such a partner -notification programme should be introduced 
in South Africa, see Roehrs 2009 SALJ 386-388. 
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taken  into  consideration.  It  is  furthermore emphasised  in  the  guidelines  that  the 
decision is to be made with great care and that consideration is to be given to the 
rights of all of the parties concerned. The guidelines include recommendations to 
guide the health care worker through the decision-making process, as well as the 
procedure to be followed before the disclosure of the information to the intimate 
partner.  
 
The pre-disclosure procedure  (in terms of the HPCSA guidelines)  basically entails 
that the patient is counselled and that the importance of disclosure to the intimate 
partner is emphasised, as well as the behavioural changes the patient is required to 
make. Support must be offered to the patient throughout the disclosure process and 
only if the patient continues to refuse to disclose his or her status to the intimate 
partner himself or herself is the healthcare practitioner allowed to disclose the HIV 
status of the patient to the intimate partner without the patient’s consent. However, 
the patient must be informed by the healthcare practitioner of this action, it must be 
explained to the patient that it is the healthcare practitioner’s ethical duty to divulge 
the information, and the patient must also be counselled on the possible adverse 
consequences of the disclosure.
64  
 
The  South  African  Medical  Association  (SAMA),  however,  provides  for  stricter 
guidelines re the disclosure of a patient’s HIV/AIDS status to an intimate partner, 
and it is evident from these stricter SAMA provisions that the primary duty of the 
healthcare practitioner lies with the patient and not the patient’s intimate partner(s). 
In  terms  of  the  SAMA  guidelines  the  healthcare  practitioner  may  breach  the 
confidentiality of a patient only if the partner of that patient is clearly identified, 
there is a real risk that the partner will be infected, and there is no other way to 
protect the partner other than to disclose the patient’s HIV/AIDS status.
65 Where the 
patient reasonably believes that the disclosure of his/her HIV/AIDS status entails a 
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risk of harm, the healthcare practitioner’s primary duty will be to protect the patient 
and not disclose his/her HIV/AIDS status at all.
66  
 
Yet, irrespective of whether the HPCSA or SAMA guidelines  are followed, it is clear 
that if the healthcare worker  ultimately decides to make the disclosure against the 
patient’s wishes, the healthcare worker must do so after explaining the situation to 
the patient, and the healthcare worker must then also accept full responsibility for 
the decision made and the action taken.
67  
 
With regard to the disclosure of the HIV/AIDS status of a deceased to his/her 
intimate partner McQuoid-Mason argues that such a disclosure can  be regarded as 
being in the public interest, that there is a legal duty on medical practitioners to 
warn the intimate partners of HIV-positive deceased persons, and that failure to do 
so may result in legal action by the dependants of such spouses or sexual partners 
should they incur any loss or damage as a result of being unaware of their HIV 
status.
68  
 
It is unclear to date whether or not a healthcare practitioner’s general ethical duty to 
protect  others  from  harm  and  inform  them  of  possible  health  risks  will  be  a 
justifiable limitation of his/her patient’s right to privacy and confidentiality in terms 
of the patient’s HIV/AIDS status. Roehrs argues that various factors will have to be 
taken into consideration, including whether there is a legal duty on the healthcare 
practitioner to act, whether there is a special relationship between the healthcare 
practitioner and the particular patient’s intimate partner, what the boni mores of the 
community warrants in such a situation, what the particular patient’s responsibilities 
are  towards  their  intimate  partner(s),  and  whether  these  responsibilities  may  be 
conferred upon healthcare practitioners by their patients.
69  
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7  Disclosure and compulsory HIV-testing  
 
Chapter 5 of the Criminal Law (Sexual Offences and Related Matters) Amendment 
Act  32  of  2007  came  into  operation  on  21  March  2008  and  provides  for  the 
compulsory HIV testing of alleged sex offenders. (In the United States, California, 
Colorado and Texas have similar legislative measures, compelling the HIV testing of 
rape suspects.)
70 Sections 30 and 28 of the Sexual Offences and Related Matters Act 
make provision for the victim of a sexual offence (or any interested person on behalf 
of such a victim, who obtained the required consent from the victim) to apply to a 
magistrate for an order that the alleged offender be tested for HIV and that the 
results thereof be disclosed to the victim or the interested person, as well as the 
alleged offender.
71 This application must be brought within 90 days after the alleged 
commission of the offence concerned, and may be made before or after an arrest 
has been effected.
72 
 
It is  furthermore  a requirement for this application to confirm that the alleged 
offence was reported to the police within 72 hours after the alleged commission of 
the offence or that it was reported at a designated health establishment within the 
same time limit.
73 The application must be handed to the investigating officer of the 
particular  case,  and  the  investigat ing  officer  must,  as  soon  as  is  reasonably 
practicable, submit the application to a magistrate of the district in which the sexual 
offence is alleged to have been committed.
74 
 
The  magistrate  will  then,  as  soon  as  is  reasonably  practicable,  consider  the 
application and may call for additional evidence as he/she deems fit, including 
evidence by or on behalf of the alleged offender.
75 If the magistrate is satisfied that 
there is prima facie evidence that a sexual offence was committed against the victim 
                                                 
70   Bedward 1990 U Ill L Rev 347. Also see The Penal Code of California: a 1524; Colorado Revised 
Statutes: Criminal Code - aa 18-3-415; Texas Code of Criminal Procedure: a 21.31.  
71   Section 30(1)(a)(i) Criminal Law (Sexual Offences and Related Matters) Amendment Act 32 of 
2007 (hereafter "Sexual Offences and Related Matters Act"). 
72   Section 30(3) Sexual Offences and Related Matters Act. 
73   Sections 28(a) and 30(2)(a)(ii) Sexual Offences and Related Matters Act. 
74   Section 30(4) Sexual Offences and Related Matters Act. 
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by the alleged offender, that the victim may have been exposed to the body fluids of 
the alleged offender, and that no more than 90 calendar days have elapsed from the 
date on which it is alleged that the offence in question took place, the magistrate 
must order that the alleged offender undergo an HIV test and that the results of this 
test be disclosed in the prescribed manner to the victim or interested person acting 
on behalf of the victim, as well as to the alleged offender.
76  
 
An alleged offender who fails or refuses to comply or avoids complying with an order 
to undergo a compulsory HIV test is guilty of an offence and is liable on conviction 
to a fine or imprisonment for a period not exceeding three years.
77 Any person who, 
with malicious intent, lays a charg e with the SAPS in respect of an alleged sexual 
offence and makes an application in terms of section 30(1) with the intention of 
ascertaining the HIV status of any person is also guilty of an offence and is liable on 
conviction to a fine or imprisonment for a period not exceeding three years.
78 
 
In terms of section 32 of the A ct, an investigating officer may also apply for the 
compulsory HIV-testing of an alleged offender and in this instance the type of crime 
that the offender allegedly committed is not confined to a sexual offence. Instead it 
includes any offence in which the HIV status of the offender may be relevant for the 
purposes of investigation or prosecution.  If the magistrate in such an instance is 
satisfied that there is  prima facie evidence that  a sexual offence or  other kind of 
offence has been committed by the offender and that a n HIV test would appear to 
be necessary for  the  purposes of investigating or prosecuting the offence, the 
magistrate must order that the alleged offender undergo the HIV test.
79 
 
The fact that an order for the HIV testing of an alleged offender has been granted in 
terms of sections 31 and 32 of the A ct may be communicated  only to the victim 
and/or  interested  person(s),  the  alleged  offender,  the  investigating  officer ,  the 
                                                 
76   Section 31(3) Sexual Offences and Related Matters Act.  
77   Section 38(2) Sexual Offences and Related Matters Act.  
78   Section 38(1)(a) Sexual Offences and Related Matters Act.  The institution of a prosecution for 
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prosecutor where applicable, the persons who are required to execute the order, and 
any person who needs to know the test results for the purposes of any criminal of 
civil proceeding.
80 A sealed record of the test results must be handed to the victim 
and/or interested person(s), as well as  to the alleged offender.
81 The test results 
may  furthermore  be  used  only  in  connection  with  the  alleged  offence  under 
investigation.
82 Any person who with malicious intent or gross negligence disclose s 
the results of any HIV  test in contravention  of section 37 of the A ct (as set out 
above) is guilty of an offence and liable to a fine or imprisonm ent for a period that 
may not exceed three years.
83 
 
Although the high prevalence of both sexual violence and HIV/AIDS in South Africa  
certainly warrants the protection of  the victims of sexual crimes and the enabling 
provisions dealing with the compulsory HIV -testing  and disclosure  of alleged sex 
offenders in the  Criminal Law (Sexual Offences and Related Matters) Amendment 
Act  32 of 2007, it  remains doubtful  if  these litigious provisions of the Act  are 
justifiable.
84 The transmission of HIV/AIDS from the perpetrator to the victim of a 
sex crime is usually prevented by the use of post-exposure prophylaxis (PEP). PEP is 
a 28-day regimen of  antiretroviral drugs which may prevent the transmission of 
HIV/AIDS and is given to victims up to 72 hours after the sexual violence had 
occurred. It is highly unlikely, however ,  that the procedures provided for in the 
Criminal Law (Sexual Offences and Related Matters) Amendment Act 32 of 2007 will 
be concluded within the 72 -hour period  within which  the  PEP regimen must be 
started. Also, if the perpetrator is in the window period of his/her HIV infection, in 
other words the first 3 to 6  weeks, or sometimes up to 12 weeks after the initial 
infection, during which period HIV antibody tests cannot detect the antibodies to the 
virus in the blood, the compulsory HIV test provided for in the Act will also be of no 
                                                 
80   Sections 36, 37 Sexual Offences and Related Matters Act. 
81   Section 33 Sexual Offences and Related Matters Act.  
82   Section 34 Sexual Offences and Related Matters Act.  
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value  to  the  victim,  as  the  test  result  will  be  negative  despite  the  perpetrator’s 
positive status.
85  
 
Thus, victims of sex crimes should  always use PEP as soon as possible after an 
attack  and  should  definitely  not  wait  for  the  outcome  of  the  legal  procedures 
described above.
86  The serious infringement of  these mandatory provisions on a 
suspect’s rights to be presumed innocent and the right to privacy and confidentiality 
is certainly debatable in the light of the uncertain value that the test results may 
hold for the victims of sex crime.
87  
 
8  Disclosure of the HIV-status of a healthcare worker
88  
 
The question of whether or not mandatory HIV testing should be implemented for all 
healthcare  workers  was  raised  in  a  2008-2009  cross-sectional  survey  amongst 
members of the Association of Surgeons of South Africa.
89 It was submitted that all 
healthcare workers should know their status for the purpose of de -stigmatising the 
illness and promoting safer practices overall. A substantial majority of the surgeons 
were against such mandatory testing. They perceived it as d iscriminatory if only 
surgeons and none of the other health professions were to subject themselves to 
such mandatory testing, and they also submitted that it  would undermine surgeon 
autonomy.
90 However, calls for such compulsory and/or routine testing are o n the 
increase amongst some of the health professions, while others argue that strict and 
standard  precautionary  measures  should  always  be  employed  to  prevent  HIV -
infection of their patients by healthcare workers. It is submitted by those who argue 
for strict and standard precautionary measures instead of mandatory and routine 
follow-up  testing  that  the  standard  precautionary  measures  will  in  actual  fact 
preclude the requirement of mandatory and/or routine testing, as it will ensure that 
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86   Roehrs 2009 SALJ 394.  
87   Roehrs 2009 SALJ 396.  
88   For research on the disclosure of the HIV/AIDS status of educators and other officials in 
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the safest possible practices will always be employed, thereby limiting any risk of 
infection and contamination.
91 
 
Various guidelines and policy documents pronouncing on the management of HIV -
infected practitioners exists. The 1991 guidelines issued by the Centres for Diseas e 
Control and Prevention (CDC) focus specifically on the prevention of the transmission 
of  HIV  and  the  hepatitis  B  virus  from  healthcare  worker s  to  patients.  These 
guidelines, however,  have been  criticised  on the grounds that they   discriminate 
against practitioners without really contributing to and serving the best interests of 
patients.
92 The guidelines issued by the Health Professions Council of South Africa 
(HPCSA) for the management of patients infected with HIV or AIDS also provide for 
the  management  o f  infected  practitioners.  These  guidelines  contain 
recommendations with regard to such a practitioner’s continuation in practice, the 
disclosure of his/her status, and the need to seek medical treatment and counselling. 
With regard to the disclosure of such a practitioner’s status, the guidelines place no 
duty or obligation on the practitioner to disclose.
93 Similarly, the guidelines of the 
South  African  Medical  Association  also  place  no  obligation  on  HIV -positive 
practitioners to disclose their status to patients, employers or co-workers. It is only 
recommended for HIV-infected practitioners to consider modifying their practice so 
as not to place patients at risk.
94  
 
It is argued that a patient’s knowledge of a practitioner’s HIV-status would not be in 
the  patient’s  best  interest  as  it  might  deter  patients  from  undergoing  certain 
necessary treatments which they believe might put them at risk, or it might deter 
patients from consulting HIV-infected practitioners simply because the practitioner is 
HIV-positive and not because of any doubt of the practitioner’s skills and expertise.
95 
The  possibility  also  exists  for  patients  to  disseminate  the  information  of  a 
                                                 
91   Falk-Kessler, Barnowski and Salvant 1994 Am J Occup Ther 27-37; McQuoid-Mason 2007a SAMJ 
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practitioner’s HIV-status to others, as patients are not bound by ethical codes with 
regard to confidentiality.
96  
 
If, however, a practitioner’s HIV-status is paramount to the diagnostic procedures 
and treatment options recommended in a particular instance, and it the practitioner’s 
status  might  represent  a  risk,  cost  or  consequence  to  the  patient,  it  must  be 
disclosed in terms of section 6(b) and 6(c) of the National Health Act 61 of 2003.
97 
 
9  Disclosure,  confidentiality  and  home-based  care  for  HIV-infected 
patients  
 
With more than 33.3 million people living with HIV/AIDS worldwide and 16.6 million 
deaths  due  to  AIDS-related  illnesses  recorded  in  2009,  home-based  care  for 
HIV/AIDS patients has become necessary in order to cope with the great demands 
placed on the healthcare sector, specifically with regard to hospitalisation and the 
continuity of care for patients.
98 The policy with regard to the confidentiality of a n 
HIV diagnosis remains, however, and the term  "chronic illnesses" is now a generic 
label used in public health documents to conceal HIV/AIDS as the primary source of 
such chronic conditions of poor health.
99 Yet maintaining the confidentiality of HIV 
patients and keeping pertinent information with regard to the illness from primary 
caregivers is controversial.
100  
 
While the right to privacy and confidentiality of HIV/AIDS patients is central, it is 
submitted  that  it  also  marginalises  caregivers ,  who  assume  the  bulk  of  the 
responsibility  for  the patient’s  wellbeing  and  are  expected  to  adhere  to  standard 
precautions  to  prevent  HIV  infection.
101  The  extension  of  the  healer -patient 
relationship (discussed in part 4 above) to include caregivers and home-based care 
rather requires shared responsibility and confidentiality ,  together with the health 
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care worker. Such a principle of shared responsibility and confidentiality, it is argued, 
also  has  the  potential  of  de-stigmatising  HIV/AIDS  in  those  "…  resource-poor 
contexts  where  families  and  communities  shoulder  most  of  the  care 
responsibility".
102  Moreover, the notion of shared responsibility and confidentiality 
coincides  with  the  African  Ubuntu  philosophy  that  prov ides  the  basis  of  social 
cohesion  in  African  culture.
103  In  terms  of  the  Ubuntu  philosophy  human 
relationships  are  based  on  interdependence,  trust,  openness,  and  shared 
responsibility, reflecting a cultural value of communality and sharing.
104 
 
But while such shared responsibility and confidentiality may be in the best interests 
of the patient when it comes to the continuity and quality of home -based care, 
public health experts agreed at the 2001 Health Summit that HIV and AIDS should 
not be made a notifiable disease.
105 It was generally agreed that the stigma was too 
severe  and  that  the  compulsory  disclosure  of  an  individual’s  status  was  not 
conducive of effective public health practice and management.
106 
 
10  Disclosing the HIV/AIDS status of deceased patients  
 
According  to  the  ethical  rules  of  the  Health  Professions  Council  of  South  Africa 
(HPCSA), the confidential information about a deceased patient (including his or her 
HIV-status) may be disclosed only if the written consent of that deceased person’s 
next-of-kin is obtained, or if the written permission of the executor of the deceased 
person’s estate is obtained.
107 Deviation from this general principle will be allowed 
only if the deceased’s personal information must be disclosed in terms of a statute or 
                                                 
102   Makoae and Jubber 2008 SAHARA J 38. 
103   Makoae and Jubber 2008 SAHARA J 38. 
104   Makoae and Jubber 2008 SAHARA J 38. 
105   Healthcare practitioners diagnosing a notifiable disease have an obligation to inform the local 
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control the spread of the disease by locating and contacting infected indi viduals and possibly 
submitting them to coercive measures and/or passively enabling the accurate surveillance of the 
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a court order, or if the disclosure is justified in the public interest.
108 It is therefore 
evident that in terms of the law there is no special protection for the deceased’s 
right to privacy and confidentiality.
109 
 
However, medical practitioners  continue indirectly to protect the confidentiality of 
the deceased when completing the compulsory BI 1663 form (the death certificate) 
in terms of the  Births and Deaths Registration Act 51 of 1992.
110 The first page of 
the BI 1663 form is for the purposes of registering the death with the Department of 
Home Affairs and issuing a burial order, and the second page is required for medico-
legal and statistical purposes.
111 This second page contains the demographic details 
of the deceased as well as the cause of death.
112 While the second page of the BI 
1663  form  is  supposed  to  be  sealed  and  attached  to  the  first,  the  notion  of 
confidentiality with regard to the deceased’s cause of death is an illusion, as home 
affairs officials and funeral undertakers have to check the serial numbers, surnames, 
first  names  and  demographic  information  of  the  deceased  with  the  information 
contained on the first page.
113 It is for this reason that many medical practitioners 
are wary of indicating the cause of death due to AIDS-related illnesses.
114  
 
It is submitted by McQuoid-Mason that such practices are unethical, as rule 12 of the 
HPCSA recognises that a statute may require disclosure w ith regard to a deceased 
person’s  health  status  to  be  made.  Also,  the  law  imposes  a  duty  upon  medical 
practitioners to provide the correct information on the BI 1663 form (irrespective of 
the  confidentiality  concerns)  and  failure  to  do  so  is  a  criminal  offence  liable  on 
conviction to a fine or imprisonment of 5 years or both.
115 
 
                                                 
108   McQuoid-Mason 2007b SAMJ 920-923; Spendiff v East London Despatch Ltd 1929 EDL 113. 
109   McQuoid-Mason 2007b SAMJ 920-923. 
110   McQuoid-Mason 2007b SAMJ 920-923. 
111   It is said that the purpose of the BI 1663 form is to improve statistics on the cause of death, and 
this information is used to allow for the proper monitoring and development of health policies 
(McQuoid-Mason 2007b SAMJ 920-923). 
112   McQuoid-Mason 2007b SAMJ 920-923. 
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11  Disclosure and the HIV status of minors  
 
Should  a  minor/child  be  told  the  truth  about  his/her  HIV  status?  Can  minors  be 
forced to undergo HIV testing, or when is a minor old enough to be told that he/she 
is  HIV  positive?  While  it  has  already  been  established  that  the  disclosure  of  an 
adult’s HIV status is a contentious issue, the disclosure of the status of a minor is 
even more complex and multilayered. It is said that the disclosure of a child’s status 
is  multilayered  as  it  includes  the  disclosure  of  the  information  to  the  child,  the 
parents of the child and other siblings or family members, as well as the anticipation 
of  the  child’s  own  disclosure  of  this  information  to  friends,  family  and  the 
community.
116  Moreover, while the disclosure of the HIV status of an adult has 
received considerable attention  in research and guidance documents, there are no 
guidelines on the paediatric disclosure of HIV/AIDS in South Africa.
117 
 
Although the early disclosure of a child’s HIV status holds therapeutic value – in that 
the child will understand the risks and will generally cooperate in the treatment – it 
is advised that very young children under the age of 5 years or children with a 
developmental  delay,  or  with  poor  intellectual  capabilities,  and/or  children  with 
severe emotional disturbances not be informed of their status. Such children should 
rather be assessed periodically and the information should be disclosed only if their 
circumstances  change  for  the  better.
118  The  American  Academy  of  Paediatrics 
furthermore emphasises the role of counselling before and after the disclosure, that 
the disclosure is individualised in order to meet the specific child’s needs, and that 
the information provided must correspond with the specific child’s cognitive ability, 
developmental stage, clinical status and social circumstances.
119 Moodley et al also 
warn that when and how a parent discloses to a child can affect the provision of 
care  for  the  child  and  may  influence  the  child’s  psychosocial  adjustment  and 
development.
120 
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Section 130(1) of the Children’s Act 38 of 2005 provides that no child may be tested 
for HIV unless it is in the best interest of the child and consent was given in terms of 
section  130(2)  of  the  Act  or  if  the  test  is  necessary  to  establish  if  a  healthcare 
worker (or any other person) may have contracted HIV due to contact with any 
substance from the child’s body that may transmit HIV.  
 
Section 130(2)(a) of the Act states that consent for an HIV test on a child may be 
given by the child only if the child is 12 years of age or older or under the age of 12 
years  but  is  of  sufficient  maturity  to  understand  the  benefits,  risks  and  social 
implications of such a test.
121 Where the child is under the age of 12 and is not of 
sufficient maturity to understand the benefits, risks and social implications of the 
test the following persons may give consent on behalf of the child: the child’s parent 
or  caregiver,
122  the provincial head of social development,
123  a designated child 
protection  organisation  arranging  the  placement  of  the  child,
124  and  the 
superintendent or person in charge of a ho spital if the child has no parent or 
caregiver and there is no designated child protection organisation arranging for the 
placement of the child.
125 The children’s court may give consent on behalf of the 
child  only  if  the  consent  by  the  roleplayers  referred  to  above  and  in  section 
130(2)(a) to (d) of the Act is unreasonably withheld or the child or the parent or the 
caregiver of the child is incapable of giving consent.
126 
 
The Act furthermore provides for required counselling before and after testing,
127 as 
well  as  for  the  confidentiality  of  the  information  on  the  HIV/AIDS  status  of 
children.
128 Section 133 prohibits anybody from disclosing the HIV status of a child 
without the consent given by the child if the child is 12 years of age or older or is 
under the age of 12 years and is of sufficient maturity to understand the benefits, 
                                                 
121   Also see s 10 of the Children’s Act 38 of 2005 re child participation.  
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risks and social implications of such disclosure.
129 Consent on behalf of the child by 
the parent or caregiver, a designated child protection organisation arranging the 
placement of the child, the superintendent or person in charge of a hospital and the 
children’s court is provided for  mutatis mutandis as in section 130 of the Act.
130 
However,  disclosure  of  a  child’s  HIV/AIDS  status  is  permitted  in  those  instances 
where it falls within the scope of a particular person’s powers and duties in terms of 
the Children’s Act or any other law that warrants the disclosure,
131 or when it is 
necessary for the purpose of carrying out the provisions of the  Children’s Act,
132 or 
for the purpose of legal proceedings,
133 or in terms of a court order.
134 
 
With regard to the treatment of minors specifically for HIV/AIDS the Children’s Act is 
silent. It is interesting to note, however, that section 39(4)(b) of the now repealed 
Child Care Act 74 of 1983 did make specific provision for consent and the treatment 
of minors with HIV/AIDS. In terms of the Child Care Act a minor (a person under the 
age of 18 years) generally required the consent of a parent or caregiver in order to 
undergo medical treatment.  Section 39(4)(b) of the Child Care Act provided that 
children over the age of 14 years but still under 18 years could consent to medical 
treatment without the assistance of a parent or guardian/caregiver.   
 
Paediatric disclosure of HIV status is becoming increasingly important, due not only 
to the prevalence of HIV in South Africa but also to the scale-up of HIV treatment 
services in many parts of South Africa.
135 The current provisions of the Children’s Act 
and  Child  Care  Act  discussed  above  also  do  not  give  due  regard  to  the  ethical 
conflicts that may exist between the autonomy of the consent giver vs the autonomy 
of the child, or the autonomy of the consent giver and the obligation to tell the 
truth, or the beneficence of knowing vs non maleficence.
136 Greater attention should 
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132   Section 133(1)(b) Children’s Act 38 of 2005. 
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therefore be given to issues of the HIV testing and disclosure of infected minors, as 
this may contribute to the improved quality of long-term care.
137 
 
12  Disclosure of school learners’ HIV status   
 
The impact of HIV/AIDS on children and the stigma associated therewith directly 
jeopardise  a  child’s  right  inter  alia  to  education.
138  Research indicates that HIV -
positive learners are isolated and are often the target of other children’s humiliation 
and  bullying.
139  In the case of  Perreira v Buccleuch  Montessori Pr e-school and 
Primary (Pty) Ltd,
140 for example, it was alleged that  a child was denied access to 
the school because of his HIV status.  However, the disclosure of the HIV status of 
teachers is just as problematic, as it is said that teachers living with AIDS  are also 
seriously discriminated against by school managers, teaching colleagues and the 
students.
141  
 
There are two guidance documents that address the disclosure of HIV/AIDS in the 
context of education. First,  Statement 1998:10 by the Department of Educat ion 
states that all information pertaining to the medical condition of a learner, student or 
educator with HIV/AIDS must be kept confidential and that disclosure to third parties 
can be authorised only with the individual’s informed consent.
142 The National Policy 
on  HIV/AIDS  for  learners  and  educators  in  public  schools  and  students  and 
educators  in  further  education  and  training  institutions
143  also  prohibits  the 
mandatory testing of learners, students or educators and dismiss es the notion of 
routine testing as there is said to be no medical justification for such programmes.
144 
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13  Conclusion 
 
The non-consensual or inappropriate disclosure of another person’s HIV/AIDS status 
may put the infected individual at great risk of human rights violations, including 
rejection, ostracism, unfair discrimination, the disruption of family relations, violence, 
sexual abuse or abandonment.
145 It may also affect the individual’s employment, 
whether he/she may become a member of a medical aid scheme, life insurance, 
bonds and the general quality of life. Respect for a person’s right to privacy and 
confidentiality (in the latter instance where information was disclosed in a special 
relationship  between  parties)  therefore  remains  –  irrespective  of  the  particular 
context – the most important consideration in the treatment and management of 
HIV/AIDS. Not only does the preservation of confidentiality protect the privacy of the 
patient,  but  it  also  secures  public  health  in  general,  as  health  practitioners  will 
largely be discredited when patients trust and confidentiality is breached.
146 It is only 
with due regard to the privacy and autonomy of those infected or suffering from 
HIV/AIDS that we will be able to encourage those individuals to seek treatment and 
to disclose their HIV status themselves.  
 
It is also due to the lack of standardised guidelines on the modalities of managing 
HIV disclosure in different contexts that patients’ rights to privacy, autonomy and 
confidentiality  should  be  used  as  the  primary  parameter  in  the  disclosure  of 
HIV/AIDS  statuses.
147  The  right  to  privacy  in  South  Africa  is  protected  as  an 
independent  personality  right  in  section  14  of  the  Constitution.  Privacy  is  also 
included within the concept  dignitas, and is closely intertwined with the right to 
bodily and psychological integrity.
148  Privacy is, moreover, closely related to the 
concept of identity and it has been held that the right to privacy is not based on a 
notion of the unencumbered self but  actually on the notion of what is necessary to 
have one's own autonomous identity.
149 The Consumer Protection Act 68 of 2008 
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furthermore protects individuals’ right to privacy in the context of consumer markets 
and consumer rights. It is said to present the most comprehensive set of consumer 
rights  relating  to  privacy  and  within  the  context  of  consumer  markets,  which 
certainly apply to healthcare providers as well.
150 
 
It is submitted that the question  of whether or not to disclose the HIV/AIDS status 
of  a  person  in  different  contexts  should  be  addressed  through  a  rights -based 
approach and with specific consideration of the individual’s rights to privacy, dignity, 
and bodily and psychological integrity. It is only by means of such a rights-based 
approach that the aspirations for public health and human rights in the context of 
HIV/AIDS can truly be realised. 
151  
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